SCHEMBL4959121

SCHEMBL4959121

O=S(=O)(CCc1ccc2[nH]c3ncccc3c2c1)c1cccs1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.43
MMP2 P08253 2/20 0.39
TSHR P16473 3/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
ALOX15 P16050 1/20 0.38
OPRK1 P41145 1/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TLR9 Q9NR96 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
KMT2A Q03164 4/20 0.38
MEN1 O00255 2/20 0.38
CHEK1 O14757 1/20 0.37
NFKBIA P25963 1/20 0.37
RELA Q04206 1/20 0.37
GLO1 Q04760 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.35
MAPT P10636 2/20 0.35
HTR6 P50406 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4959184 0.89 BRD4 (0.44) BRD4MMP2TSHRLMNATP53
SCHEMBL4960654 0.82 CHRM2 (0.44) BRD4KMT2AMEN1CHEK1GLO1
SCHEMBL14594976 0.77 BRD4 (0.69) BRD4MMP2TSHRLMNATP53
SCHEMBL14594982 0.74 BRD4 (0.43) BRD4MMP2TSHRLMNATP53
SCHEMBL4959114 0.74 BRD4 (0.43) BRD4MMP2TSHRLMNATP53
SCHEMBL4960991 0.73 RIPK1 (0.50) KMT2AMEN1CHEK1MAPTKDM4E
SCHEMBL4960536 0.73 EGFR (0.37) BRD4KMT2AKDM4EHPGDCYP1A2
SCHEMBL4958627 0.72 MEN1 (0.42) BRD4KMT2AMEN1CHEK1SMN1; SMN2
SCHEMBL4960713 0.70 CHEK1 (0.49) LMNAHTTKMT2AMEN1CHEK1
SCHEMBL14594938 0.70 ALK (0.51)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1896472-A1 ALPHA-CARBOLINES AS CDK-1 INHIBITORS Boehringer Ingelheim International GmbH (DE) 2008-03-12 EP disclosed
WO-2006131552-A1 ALPHA-CARBOLINES AS CDK-1 INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-12-14 WO disclosed